BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26589741)

  • 1. Extreme obesity does not predict poor cancer outcomes after surgery for renal cell cancer.
    Blute ML; Zorn K; Grimes M; Shi F; Downs TM; Jarrard DF; Best SL; Richards K; Nakada SY; Abel EJ
    BJU Int; 2016 Sep; 118(3):399-407. PubMed ID: 26589741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma.
    Rogde AJ; Gudbrandsdottir G; Hjelle KM; Sand KE; Bostad L; Beisland C
    Scand J Urol Nephrol; 2012 Oct; 46(5):348-57. PubMed ID: 22530756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis.
    Choi Y; Park B; Jeong BC; Seo SI; Jeon SS; Choi HY; Adami HO; Lee JE; Lee HM
    Int J Cancer; 2013 Feb; 132(3):625-34. PubMed ID: 22610826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy.
    Spiess PE; Kurian T; Lin HY; Rawal B; Kim T; Sexton WJ; Pow-Sang JM
    BJU Int; 2012 Dec; 110(11 Pt B):E470-4. PubMed ID: 22519938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Critical Analysis of Perioperative Outcomes in Morbidly Obese Patients Following Renal Mass Surgery.
    Grimes MD; Blute ML; Wittmann TA; Mann MA; Zorn K; Downs TM; Shi F; Jarrard DF; Best SL; Richards KA; Nakada SY; Abel EJ
    Urology; 2016 Oct; 96():93-98. PubMed ID: 27339026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent prognostic value of body mass index for non-metastatic clear cell renal cell carcinoma: A large multicenter retrospective analysis.
    Byun SS; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kim HH; Kwak C; Kim YJ; Lee WK
    J Surg Oncol; 2018 Jul; 118(1):199-205. PubMed ID: 29949668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of body mass index and weight loss on cancer-specific and overall survival in patients with surgically resected renal cell carcinoma.
    Brookman-May S; Kendel F; Hoschke B; Wieland WF; Burger M; Rössler W; May M
    Scand J Urol Nephrol; 2011 Feb; 45(1):5-14. PubMed ID: 20846080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes.
    Albisinni S; Pretot D; Al Hajj Obeid W; Aoun F; Quackels T; Peltier A; Roumeguère T
    Prog Urol; 2019; 29(8-9):423-431. PubMed ID: 31196826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Body Mass Index According to Histologic Subtype in Nonmetastatic Renal Cell Carcinoma: A Large Cohort Analysis.
    Lee WK; Hong SK; Lee S; Kwak C; Oh JJ; Jeong CW; Kim YJ; Kang SH; Hong SH; Byun SS
    Clin Genitourin Cancer; 2015 Oct; 13(5):461-8. PubMed ID: 25990340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of body mass index by gender on oncological outcomes in patients with renal cell carcinoma.
    Balci M; Glaser ZA; Chang SS; Herrell SD; Barocas DA; Keegan KA; Moses KA; Resnick MJ; Smith JA; Penson DF; Scarpato K; Clark PE
    J Cancer Res Ther; 2021; 17(2):420-425. PubMed ID: 34121687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of tumor size on patient survival after radical nephrectomy for pathological T3a renal cell carcinoma.
    Sugiyama Y; Yatsuda J; Murakami Y; Ito N; Yamasaki T; Mikami Y; Ogawa O; Kamba T
    Jpn J Clin Oncol; 2019 May; 49(5):465-472. PubMed ID: 30793163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-institutional analysis of localized renal cell carcinoma that demonstrates the impact of diabetic status on prognosis after nephrectomy.
    Ha YS; Kim WT; Yun SJ; Lee SC; Kim WJ; Park YH; Kang SH; Hong SH; Byun SS; Kim YJ
    Ann Surg Oncol; 2013 Oct; 20(11):3662-8. PubMed ID: 23907313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.
    Kim KH; You D; Jeong IG; Kwon TW; Cho YM; Hong JH; Ahn H; Kim CS
    BJU Int; 2012 Dec; 110(11 Pt B):E673-8. PubMed ID: 22973869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma.
    Kara O; Maurice MJ; Zargar H; Malkoc E; Akca O; Andrade HS; Ramirez D; Caputo PA; Nelson RJ; Rini B; Kaouk JH
    Int Urol Nephrol; 2016 Aug; 48(8):1253-1260. PubMed ID: 27215555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
    O'Malley RL; Hayn MH; Brewer KA; Underwood W; Hellenthal NJ; Kim HL; Sorokin I; Schwaab T
    World J Urol; 2015 Nov; 33(11):1807-14. PubMed ID: 25805189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of perioperative blood transfusion on oncologic outcomes in patients with nonmetastatic renal cell carcinoma treated with curative nephrectomy: A retrospective analysis of a large, single-institutional cohort.
    Seon DY; Kwak C; Kim HH; Ku JH; Kim HS
    Investig Clin Urol; 2020 Mar; 61(2):136-145. PubMed ID: 32158964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality Increases When Radical Nephrectomy is Delayed More Than 60 Days for T3 Renal Cell Carcinoma.
    Zhao F; Liu X; Zhang C; Zhu H; Qi N
    Technol Cancer Res Treat; 2021; 20():15330338211043963. PubMed ID: 34595976
    [No Abstract]   [Full Text] [Related]  

  • 19. Percutaneous renal cryoablation in obese and morbidly obese patients.
    Schmit GD; Thompson RH; Boorjian SA; McDonald RJ; Kurup AN; Weisbrod AJ; Kor DJ; Callstrom MR; Atwell TD
    Urology; 2013 Sep; 82(3):636-41. PubMed ID: 23890665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of ABO blood group in patients with renal cell carcinoma: single-institution results from a large cohort.
    Lee C; You D; Sohn M; Jeong IG; Song C; Kwon T; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1441-7. PubMed ID: 25687379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.